Immuneering OverviewImmuneering Net Income
Profitability analysis for IMRX.
Quarterly Net Income
-$13.46B
↑ 10.54% YoY
As of Mar 2026
Annual Net Income (TTM)
-$28.45B
↑ 4.12% YoY
Trailing 12 months ending Mar 2026
Average Net Income (Comparison Companies)
Net Income History
Net Income Comparison
Annual Net Income Growth Rate (%)
Loading...
Annual Net Income Growth (Absolute)
Loading...